Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
bullish
China Feihe
Watchlist
China Feihe (中国飞鹤) IPO Trading - Allocation, Peer Performance, and Upside
Equity Capital Markets
548 Views
13 Nov 2019 03:46
China Feihe, the largest domestic infant milk formula (IMF) player, raised USD 847 million at HKD 7.50 per share. In this insight, we will cover...
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 4-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Equity Derivatives
Event-Driven
Equity Bottom-Up
India
Japan
Index Rebalance
South Korea
Philippines
Singapore
Hong Kong
Trending Insights
More »
HEW: Poorly Positioned Doves
Tam Jai (2217 HK): Toridoll (3397 JP)'s Excellent Offer. Still.
STTF Index Rebalance: Keppel DC REIT Replaces Jardine Cycle & Carriage
Great Eastern (GE SP): OCBC Bumps Terms - $30.15/Share Exit Offer
Event-Driven Optionality in ProSieben: Playing the Floor, Targeting the Upside
Top Unpaywalled Insights
More »
[IO Technicals 2025/23] Bearish Momentum Persists
VEON US: Pakistan Towers Sale Frees Capital for Digital Growth in Core Market Ahead of Ukraine IPO
Advanced Look: Navigating the New Macro Landscape Through Quantitative Alpha Generation Strategies
[IO Technicals 2025/22] Bearish Momentum Strengthens
Texas Power Play: Grid Sovereignty, Bitcoin, and the Future of AI
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Trade Idea: China Feihe's Top Line Could Beat Today
04 Mar 2020
China Feihe (中国飞鹤) Post-IPO: Thoughts on Official Response to Short Seller Report
25 Nov 2019
China Feihe (中国飞鹤) Post-IPO: Thoughts on Short Seller Allegations
22 Nov 2019
China Feihe (中国飞鹤) IPO Trading - Allocation, Peer Performance, and Upside
13 Nov 2019
China Feihe (中国飞鹤) IPO - Wide Valuation Range, No Cornerstone, and Things to Note
28 Oct 2019
China Feihe (中国飞鹤) IPO: Peer Comparison and Thoughts on Valuation
16 Oct 2019
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x